Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder.

ABSTRACT:

SUBMITTER: Shi Z 

PROVIDER: S-EPMC10119768 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature